Streetbeat News

Revenues

GOOS

Canada Goose has acquired the operating assets of Paola Confectii Manufacturing, a Romanian knitwear supplier, marking its first European manufacturing facility. This move aligns with the company's Strategic Growth Plan to expand categories and increase year-round relevance. The acquisition is expected to enhance product margins, supply control, and in-house expertise. Knitwear is a key segment in Canada Goose's growing Apparel category, which surpassed $70 million in annual sales in fiscal 2023. The company will continue to produce core down-filled products in Canada, while expanding apparel production in Europe.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:04 pm

NNDM

Nano Dimension (NASDAQ:NNDM) reported Q3 EPS of $(0.26), which is unchanged from the same period last year. However, sales increased by 21.62% to $12.16M from $10.00M in the same quarter the previous year.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 12:57 pm

BTTX

Better Therapeutics, Inc. (NASDAQ:BTTX) has amended its debt facility with Hercules Capital, Inc. to extend the Interest Only period, redeem debt without penalties, and potentially remove the minimum cash covenant. The amendment also allows for debt-to-equity conversion under certain conditions. Additionally, Better Therapeutics is implementing cost-saving measures, including salary reductions, to improve its financial position by $5M through Q1 2024. These steps are taken to support the commercial launch of its FDA-authorized lead product, AspyreRx, for type 2 diabetes treatment.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 12:50 pm

CLCO

Cool Company Ltd. (CLCO) reported an increase in Q3 sales to $92.9M from $65.83M YoY, and a rise in net income to $39.17M from $36.77M YoY.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 12:46 pm

BABA

PDD

PDD Holdings Inc (NASDAQ:PDD) reported a significant third-quarter FY23 revenue increase of 94% year-on-year to $9.44 billion, surpassing the consensus estimate of $7.69 billion. Adjusted earnings per ADS were $1.55, beating the $1.23 consensus. The company saw a 39% increase in online marketing services revenue and a 315% jump in transaction services revenue. PDD's adjusted operating profit rose 47% Y/Y to $2.48 billion. The company has $27.8 billion in cash and equivalents and generated $4.46 billion in operating cash flow. PDD shares surged 14.68% to $135.00 in premarket trading. The stock has risen 39.3% YTD.

Portfolio Pulse from Anusuya Lahiri

November 28, 2023 | 12:44 pm

GXO

GXO Logistics has extended its agreement with Amer Sports, including added returns services. This extension solidifies GXO's position as a key logistics provider for Amer Sports, potentially increasing GXO's revenue and customer base.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 12:03 pm

BABA

Alibaba Group Holding Limited (NYSE:BABA) stock is trading lower after reports of a second outage in its cloud unit within a month. The disruption affected customers in China, Hong Kong, and the U.S., impacting various database management products. The company, which holds a significant market share in China's cloud market, also faced a similar issue in November. Concerns over the reliability of Alibaba Cloud's services have been raised. Additionally, Alibaba halted plans to spin off its cloud business and closed its quantum computing lab, signaling cost-cutting efforts. BABA shares are down 16.1% YTD and dropped 1.0% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

November 28, 2023 | 12:00 pm

CTRN

Citi Trends anticipates its Q4 total sales to be roughly the same or to increase by a low-single-digit percentage compared to Q4 of the previous year.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 11:51 am

CTRN

Citi Trends has updated its full-year sales expectations, now anticipating a mid-single-digit decline. This is a slight downgrade from its previous forecast, which ranged from a negative mid-single-digit to a negative low-single-digit decrease.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 11:50 am

BMY

RNA

Avidity Biosciences (RNA) has entered into a $2.3 billion collaboration with Bristol Myers Squibb (BMY) to develop RNA therapeutics for cardiovascular diseases. Avidity will receive $100 million upfront, including a $60 million cash payment and $40 million in common stock at $7.88 per share. The deal includes potential payments of up to $1.35 billion for R&D milestones, $825 million for commercial milestones, and royalties on net sales.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 11:45 am